sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Breast Cancer Therapeutics Market...

Europa-Marktprognose für Brustkrebstherapeutika bis 2030 – regionale Analyse – nach medikamentöser Therapie [gezielte medikamentöse Therapie (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab und andere zielgerichtete medikamentöse Therapien), hormonelle medikamentöse Therapie (selektive Östrogenrezeptor-Modulatoren, Aromatasehemmer, und selektive Östrogenrezeptor-Downregulatoren), Chemotherapie und Immuntherapie/biologische Therapie], Brustkrebstyp (Hormonrezeptor, HER2+ und dreifach negativer Brustkrebs) und Vertriebskanal (Krankenhausapotheken, Drogerien und Einzelhandelsapotheken sowie Online-Apotheken) X

BMIRE00029748 | Pages: 106 | Pharmaceuticals | Mar 2024 | Type: Regional | Status: Published
Der europäische Markt für Brustkrebstherapeutika wurde im Jahr 2022 auf 8.446,96 Millionen US-Dollar geschätzt und wird bis 2030 voraussichtlich 16.836,17 Millionen US-Dollar erreichen; Es wird geschätzt, dass es von 2022 bis 2030 mit einer jährlichen Wachstumsrate von 9,0 % wachsen wird.

Verstärkte Unterstützung durch staatliche und private Organisationen befeuert den europäischen Markt für Brustkrebstherapeutika

Regierungen verschiedener Länder erkennen die Bedeutung von Wir bekämpfen Brustkrebs und setzen Maßnahmen um, um den Zugang zu wirksamen Behandlungen zu verbessern. Viele Regierungen und private Organisationen haben die Mittel für Forschung und Entwicklung im Bereich Brustkrebstherapeutika erhöht, was zur Entwicklung innovativer Medikamente und Therapien geführt hat. Die Initiative der Europäischen Kommission zu Brustkrebs (ECIBC) bietet eine allgemein zugängliche, qualitativ hochwertige Grundversorgung auf allen Ebenen. Die Mission von ECIBC besteht darin, Frauen und medizinischem Fachpersonal unparteiische und unvoreingenommene Ratschläge zu Screening und Pflege auf der Grundlage der neuesten wissenschaftlichen Forschung zu geben. Die erhöhten Investitionen in die Forschung haben es Pharmaunternehmen ermöglicht, neue Behandlungsmöglichkeiten zu erkunden und äußerst zielgerichtete und wirksame Therapien für Brustkrebspatientinnen zu entwickeln.

Mehrere Regierungsbehörden auf der ganzen Welt unternehmen ebenfalls Schritte, um den Zugang zu diesen Behandlungen zu verbessern, indem sie Erstattungsrichtlinien und Gesundheitsinitiativen einführen, die die Kosten für Brustkrebstherapeutika für Patienten decken. Dies bedeutet, dass sich mehr Patienten diese Behandlungen leisten können und Zugang zu den neuesten Fortschritten in der Brustkrebstherapie haben. Die verstärkte staatliche Unterstützung hat auch ein günstiges Marktumfeld für Gesundheitsdienstleister geschaffen. Mit mehr verfügbaren Mitteln und Ressourcen können Gesundheitsdienstleister ihren Patienten ein breiteres Spektrum an Behandlungsmöglichkeiten anbieten. Dies verbessert die Patientenergebnisse und ermöglicht es Gesundheitsdienstleistern, auf dem Markt wettbewerbsfähig zu bleiben. Insgesamt hat die zunehmende Unterstützung von Brustkrebstherapeutika durch Regierungen und private Organisationen Innovationen vorangetrieben und zu neuen und verbesserten Behandlungen geführt. Außerdem wurde der Zugang zu diesen Behandlungen verbessert, wovon mehr Patienten profitieren. Dies stellt eine bedeutende Chance für das Wachstum des europäischen Marktes für Brustkrebstherapeutika dar, da Pharmaunternehmen und Gesundheitsdienstleister weiterhin in Forschungs- und Entwicklungsaktivitäten investieren und ihr Angebot erweitern, um der wachsenden Nachfrage gerecht zu werden.

Überblick über den europäischen Markt für Brustkrebstherapeutika

Der europäische Markt für Brustkrebstherapeutika ist in Deutschland, das Vereinigte Königreich, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Brustkrebs ist eine häufige Krebsart im Vereinigten Königreich. Nach Angaben des National Health Service (NHS) wird in Großbritannien bei etwa jeder siebten Frau im Laufe ihres Lebens Brustkrebs diagnostiziert. Jedes Jahr wird bei etwa 55.000 Frauen Brustkrebs diagnostiziert.

Die größere Nachfrage der medizinischen Industrie nach der Behandlung von Brustkrebspatientinnen mit neuartigen Therapeutika hat zu höheren Investitionen in Forschung und Entwicklung geführt und das Wachstum des Marktes angekurbelt. Breast Cancer Now ist der größte engagierte Förderer der Brustkrebsforschung im Vereinigten Königreich. Bisher wurden 308,01 Millionen US-Dollar investiert (

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Breast Cancer Therapeutics Market - Key Industry Dynamics

4.1 Key Market Drivers

4.1.1 Growing Burden of Breast Cancer

4.1.2 Launch of Several Diagnostics and Screening Programs

4.2 Key Market Restraints

4.2.1 High Cost of Diagnosis and Treatment

4.3 Key Market Opportunities

4.3.1 Increased Support from Government and Private Organizations

4.4 Key Future Trends

4.4.1 Increasing Use of Personalized Medicine

4.5 Impact Analysis:

5. Breast Cancer Therapeutics Market - Europe Market Analysis

5.1 Europe Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030

6. Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy

6.1 Overview

6.2 Europe Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)

6.3 Targeted Drug Therapy

6.3.1 Overview

6.3.2 Targeted Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.3.2.1 Europe Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)

6.4 Hormonal Drug Therapy

6.4.1 Overview

6.4.2 Hormonal Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.4.2.1 Europe Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)

6.5 Chemotherapy

6.5.1 Overview

6.5.2 Chemotherapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Immunotherapy/ Biological Therapy

6.6.1 Overview

6.6.2 Immunotherapy/ Biological Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type

7.1 Overview

7.2 Europe Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)

7.3 Hormone Receptor

7.3.1 Overview

7.3.2 Hormone Receptor: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.4 HER2+ (human epidermal growth factor receptor 2)

7.4.1 Overview

7.4.2 HER2+: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Triple-Negative Breast Cancer

7.5.1 Overview

7.5.2 Triple-Negative Breast Cancer: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 Europe Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)

8.3 Hospital Pharmacies

8.3.1 Overview

8.3.2 Hospital Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Drug Store and Retail Pharmacies

8.4.1 Overview

8.4.2 Drug Store and Retail Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Online Pharmacies

8.5.1 Overview

8.5.2 Online Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Breast Cancer Therapeutics Market - Country Analysis

9.1 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030

9.1.1 Overview

9.1.2 Europe Breast Cancer Therapeutics Market, Breakdown, by key Country- Revenue (2022) (US$ Million)

9.1.3 Europe Breast Cancer Therapeutics Market, by Country, 2022 and 2030 (%)

9.1.3.1 UK

9.1.3.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.2 Germany

9.1.3.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.3 France

9.1.3.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.4 Italy

9.1.3.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.5 Spain

9.1.3.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.6 Rest of Europe

9.1.3.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Breast Cancer Therapeutics Market-Industry Landscape

10.1 Overview

10.2 Growth Strategies in Breast Cancer Therapeutics Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Eli Lilly and Co

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Eisai Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Novartis AG

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AstraZeneca Plc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Gilead Sciences Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Merck & Co Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Teva Pharmaceutical Industries Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Amgen Inc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

 

 

List of Tables

Table 1. Europe Breast Cancer Therapeutics Market Segmentation

Table 2. Europe Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 3. Europe Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 4. UK Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 7. UK Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. UK Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 9. Germany Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 10. Germany Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 11. Germany Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 12. Germany Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 13. Germany Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 14. France Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 15. France Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 16. France Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 17. France Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 18. France Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 19. Italy Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 20. Italy Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 21. Italy Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 22. Italy Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 23. Italy Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 24. Spain Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 25. Spain Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 26. Spain Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 27. Spain Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 28. Spain Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 29. Rest of Europe Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 30. Rest of Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 31. Rest of Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 32. Rest of Europe Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 33. Rest of Europe Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 34. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market

Table 35. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market

Table 36. Glossary of Terms, Breast Cancer Therapeutics Market

List of Figures

Figure 1. Europe Breast Cancer Therapeutics Market Segmentation, By Country

Figure 2. Europe Breast Cancer Therapeutics Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030

Figure 5. Europe Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)

Figure 6. Targeted Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Hormonal Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Chemotherapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Immunotherapy/ Biological Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Europe Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)

Figure 11. Hormone Receptor: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. HER2+: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Triple-Negative Breast Cancer: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Europe Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)

Figure 15. Hospital Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Drug Store and Retail Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Online Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Europe Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)

Figure 19. Europe Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)

Figure 20. UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25. Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Growth Strategies in Breast Cancer Therapeutics Market

1. Eli Lilly and Co
2. Eisai Co Ltd
3. Novartis AG
4. AstraZeneca Plc
5. Pfizer Inc
6. Gilead Sciences Inc
7. Merck & Co Inc
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe breast cancer therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription